<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cao P</submitter><funding>NIDDK NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>19279-84</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3845181</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>110(48)</volume><pubmed_abstract>Islet amyloid polypeptide (IAPP) is responsible for amyloid formation in type 2 diabetes and contributes to the failure of islet cell transplants, however the mechanisms of IAPP-induced cytotoxicity are not known. Interactions with model anionic membranes are known to catalyze IAPP amyloid formation in vitro. Human IAPP damages anionic membranes, promoting vesicle leakage, but the features that control IAPP-membrane interactions and the connection with cellular toxicity are not clear. Kinetic studies with wild-type IAPP and IAPP mutants demonstrate that membrane leakage is induced by prefibrillar IAPP species and continues over the course of amyloid formation, correlating additional membrane disruption with fibril growth. Analyses of a set of designed mutants reveal that membrane leakage d</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>Islet amyloid polypeptide toxicity and membrane interactions.</pubmed_title><pmcid>PMC3845181</pmcid><funding_grant_id>GM078114</funding_grant_id><funding_grant_id>R01 GM078114</funding_grant_id><funding_grant_id>F32 DK089734</funding_grant_id><funding_grant_id>F32 DK089734-02</funding_grant_id><pubmed_authors>Schmidt AM</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Raleigh DP</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Cao P</pubmed_authors><pubmed_authors>Abedini A</pubmed_authors><pubmed_authors>Tu LH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Islet amyloid polypeptide toxicity and membrane interactions.</name><description>Islet amyloid polypeptide (IAPP) is responsible for amyloid formation in type 2 diabetes and contributes to the failure of islet cell transplants, however the mechanisms of IAPP-induced cytotoxicity are not known. Interactions with model anionic membranes are known to catalyze IAPP amyloid formation in vitro. Human IAPP damages anionic membranes, promoting vesicle leakage, but the features that control IAPP-membrane interactions and the connection with cellular toxicity are not clear. Kinetic studies with wild-type IAPP and IAPP mutants demonstrate that membrane leakage is induced by prefibrillar IAPP species and continues over the course of amyloid formation, correlating additional membrane disruption with fibril growth. Analyses of a set of designed mutants reveal that membrane leakage d</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Nov</publication><modification>2025-05-29T16:30:51.559Z</modification><creation>2025-05-29T16:30:51.559Z</creation></dates><accession>S-EPMC3845181</accession><cross_references><pubmed>24218607</pubmed><doi>10.1073/pnas.1305517110</doi></cross_references></HashMap>